Basal Ganglia Infarction in a Child with Disulfiram Poisoning
Pediatrics 99:605-608, Mahajan,P.&Kottamasu,S., 1997
Stroke Mechanisms and Clinical Presentation in Large Subcortical Infarctions
Neurol 49:1538-1541, Horowitz,D.&Tuhrim,S., 1997
Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Optic Atrophy and Cerebral Infarcts Caused by Methanol Intoxication:MRI
Neuroradiology 39:192-194, Hsu,H.H.,et al, 1997
MR Enhancing Brain Lesions in Methanol Intoxication
J Comput Assist Tomogr 21:834-836, Anderson,C.A.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
Specific Changes in Human Brain After Hypoglycemic Injury
Stroke 28:584-587, Fujioka,M.,et al, 1997
Fou Rire Prodromique Hearlding a Left Internal Carotid Artery Occlusion
Stroke 28:2081-2083, Carel,C.,et al, 1997
Improving Interobserver Variation in Reporting Gadolinium-Enhancing MRI Lesions in Multiple Sclerosis
Neurol 49:1682-1688, Barkhof,F.,et al, 1997
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996
MR Imaging of Creutzfeldt-Jakob Disease
Radiology 199:793-798, Finkenstaedt,M.,et al, 1996
Chorea-Ballismus with Nonketotic Hyperglycemia in Primary Diabetes Mellitus
AJNR 17:1057-1064, Lai,P.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Basal Ganglia and Thalamic Infarction in Children
Arch Neurol 53:1252-1256, Brower,M.C.,et al, 1996
Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Clinical Spectrum of CADASIL:A Study of 7 Families
Lancet 346:934-939, Chabriat,H.,et al, 1995
Juvenile Huntington Disease:CT and MR Features
AJNR 16:1405-1412, Ho,V.B.,et al, 1995
Methanol Intoxication with Putaminal & White Matter Necrosis:MR and CT Findings
AJNR 16:1492-1494, Rubenstein,D.,et al, 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Hemiballismus:CT and MR Findings
J Comput Assist Tomogr 19:537-540, Provenzale,J.M.&Glass,J.P., 1995
Bilateral Pallidostriatal Necrosis Caused by a Wasp Sting:A Clinical and Pathological Study
JNNP 58:474-476, Gallego,J.,et al, 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Postvaricella Basal Ganglia Infarction in Children
AJNR 16:449-452, Silverstein,F.S.&Brunberg,J.A., 1995
Clinical/Metabolic Correlations in Multiple System Atrophy, A PET Study
Arch Neurol 52:179-185, Perani,D.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995
Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995
MR Findings in Methanol Intoxication
AJNR 16:1783-1786, Gaul,H.P.,et al, 1995
Delayed Dystonia with Striatal CT Lucencies Induced by a Mycotoxin (3-Nitropropionic Acid)
Neurol 45:2178-2183, He,F.,et al, 1995
Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995
MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994
Striatocapsular Infarction:MRI and MR Angiography
Neuroradiology 36:430-431, Croisille,P.,et al, 1994
The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994
Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994